Clinical Trials
29 trialsNCT05131776 2026-03-23
EUS-guided Intra-tumour Injection of OncoSil for Locally Advanced Pancreatic Carcinoma.
Chinese University of Hong Kong
Phase 2/3 Terminated
NCT05171166 2025-12-18
Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial.
Peking University
Phase 2/3 Terminated
NCT05149807 2025-08-20
Clinical Study of SHR-1701 Plus Chemotherapy as Perioperative Treatment in Subjects With Gastric Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 2/3 Terminated
NCT04856787 2025-05-18
A Clinical Studyf of SHR-1701 or Placebo in Combination With BP102 and XELOX in the First-line Treatment of mCRC
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 2/3 Terminated
NCT02807181 2025-05-09
SIRCCA
Sirtex Medical
Phase 2/3 Terminated
NCT03512756 2024-11-06
A Randomized Phase 2/3 Multi-Center Study of SM-88 in Participants With Metastatic Pancreatic Cancer
Tyme, Inc
Phase 2/3 Terminated
NCT00113256 2024-08-02
Orathecin + Gemcitabine Versus Placebo + Gemcitabine in Chemonaive Non-Resectable Pancreatic Cancer
Astex Pharmaceuticals, Inc.
Phase 2/3 Terminated
NCT04066491 2023-11-14
Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L BTC
EMD Serono
Phase 2/3 Terminated
NCT02614703 2021-08-27
"Acetic Acid Chromoendoscopy in Barrett's Esophagus Surveillance
DHR Health Institute for Research and Development
Phase 2/3 Terminated
NCT01437514 2021-06-07
Effective Study of Preoperative Short-course Radiotherapy for the Advanced Resectable Rectal Cancer
West China Hospital
Phase 2/3 Terminated
NCT03158610 2021-05-03
Biological-guided Metronomic Chemotherapy as Maintenance Strategy in Metastatic Colorectal Cancer
Ruijin Hospital
Phase 2/3 Terminated
NCT01902823 2019-12-13
Effect of Cancer Nurse Navigators on Patient Outcomes
University of Wisconsin, Madison
Phase 2/3 Terminated
NCT02356640 2019-01-30
EUS-guided CGN for Inoperable Cancer
Chinese University of Hong Kong
Phase 2/3 Terminated
NCT02220088 2019-01-11
The Efficacy and Safety of Retreatment With TAI for Patients Who Showed TACE-resistant: a Randomized Controlled Trial
Sun Yat-sen University
Phase 2/3 Terminated
NCT01446874 2018-11-08
POPP
Washington University School of Medicine
Phase 2/3 Terminated
NCT02163187 2018-02-05
Sacral Neuromodulation (SNM) With InterStimTM for Bowel Dysfunction Following Surgery for Rectal Cancers With Sphincter Preservation
Memorial Sloan Kettering Cancer Center
Phase 2/3 Terminated
NCT01683864 2018-01-30
HIPECStomach
University Hospital Tuebingen
Phase 2/3 Terminated
NCT01641939 2017-05-12
A Study of Trastuzumab Emtansine Versus Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer
Hoffmann-La Roche
Phase 2/3 Terminated
NCT01704690 2017-04-07
Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer
Peking University
Phase 2/3 Terminated
NCT00332280 2013-03-20
Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo
Auron Healthcare GmbH
Phase 2/3 Terminated
NCT00405561 2013-03-20
Study to Evaluate Progression Free Survival in Cancer Patients With Advanced Colorectal Carcinoma With AMT2003
Auron Healthcare GmbH
Phase 2/3 Terminated
NCT00068744 2012-09-24
Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2/3 Terminated
NCT01259284 2012-08-07
Fish Oil Versus Statins Versus Placebos in Reducing Atrial Fibrillation in Patients Undergoing Thoracic Surgery for Lung Cancer
M.D. Anderson Cancer Center
Phase 2/3 Terminated
NCT00151671 2012-02-27
IMPACT
Rennes University Hospital
Phase 2/3 Terminated
NCT00359476 2010-03-02
A Study of Vinflunine in Patients With Gastric Cancer
Bristol-Myers Squibb
Phase 2/3 Terminated
NCT00503321 2009-01-23
eNCIT-Japan
Eastern Network of Cancer Immunological Therapy, Japan
Phase 2/3 Terminated
NCT00165633 2008-12-09
A Phase II/III Clinical Study on Inhibitory Effects of E0167 on Recurrence of Hepatocellular Carcinoma
Eisai Inc.
Phase 2/3 Terminated
NCT00034333 2005-06-24
Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads Vs. IV Doxorubicin in Treating Liver Cancer
FeRx
Phase 2/3 Terminated
NCT00057382 2005-06-24
T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma Patients
Tularik
Phase 2/3 Terminated